Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2009 | 1 |
2010 | 1 |
2013 | 2 |
2014 | 2 |
2015 | 1 |
2017 | 1 |
2018 | 1 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
Page 1
Destabilization of MYC/MYCN by the mitochondrial inhibitors, metaiodobenzylguanidine, metformin and phenformin.
Int J Mol Med. 2014 Jan;33(1):35-42. doi: 10.3892/ijmm.2013.1545. Epub 2013 Nov 1.
Int J Mol Med. 2014.
PMID: 24190252
Free PMC article.
Aurora kinase A is a possible target of OSU‑03012 to destabilize MYC family proteins.
Silva A, Wang J, Lomahan S, Tran TA, Grenlin L, Suganami A, Tamura Y, Ikegaki N.
Silva A, et al.
Oncol Rep. 2014 Sep;32(3):901-5. doi: 10.3892/or.2014.3325. Epub 2014 Jul 11.
Oncol Rep. 2014.
PMID: 25017515
Free PMC article.
Item in Clipboard
Transient treatment with epigenetic modifiers yields stable neuroblastoma stem cells resembling aggressive large-cell neuroblastomas.
Ikegaki N, Shimada H, Fox AM, Regan PL, Jacobs JR, Hicks SL, Rappaport EF, Tang XX.
Ikegaki N, et al.
Proc Natl Acad Sci U S A. 2013 Apr 9;110(15):6097-102. doi: 10.1073/pnas.1118262110. Epub 2013 Mar 11.
Proc Natl Acad Sci U S A. 2013.
PMID: 23479628
Free PMC article.
Item in Clipboard
MYC-family protein overexpression and prominent nucleolar formation represent prognostic indicators and potential therapeutic targets for aggressive high-MKI neuroblastomas: a report from the children's oncology group.
Niemas-Teshiba R, Matsuno R, Wang LL, Tang XX, Chiu B, Zeki J, Coburn J, Ornell K, Naranjo A, Van Ryn C, London WB, Hogarty MD, Gastier-Foster JM, Look AT, Park JR, Maris JM, Cohn SL, Seeger RC, Asgharzadeh S, Ikegaki N, Shimada H.
Niemas-Teshiba R, et al.
Oncotarget. 2017 Dec 15;9(5):6416-6432. doi: 10.18632/oncotarget.23740. eCollection 2018 Jan 19.
Oncotarget. 2017.
PMID: 29464082
Free PMC article.
Item in Clipboard
Biological effects of induced MYCN hyper-expression in MYCN-amplified neuroblastomas.
Torres J, Regan PL, Edo R, Leonhardt P, Jeng EI, Rappaport EF, Ikegaki N, Tang XX.
Torres J, et al.
Int J Oncol. 2010 Oct;37(4):983-91. doi: 10.3892/ijo_00000749.
Int J Oncol. 2010.
PMID: 20811720
Free PMC article.
Item in Clipboard
Augmented expression of MYC and/or MYCN protein defines highly aggressive MYC-driven neuroblastoma: a Children's Oncology Group study.
Wang LL, Teshiba R, Ikegaki N, Tang XX, Naranjo A, London WB, Hogarty MD, Gastier-Foster JM, Look AT, Park JR, Maris JM, Cohn SL, Seeger RC, Asgharzadeh S, Shimada H.
Wang LL, et al.
Br J Cancer. 2015 Jun 30;113(1):57-63. doi: 10.1038/bjc.2015.188. Epub 2015 Jun 2.
Br J Cancer. 2015.
PMID: 26035700
Free PMC article.
Item in Clipboard
Biological significance of EPHA2 expression in neuroblastoma.
Kung B, Zhao H, Hicks SL, Tang XX, Ikegaki N.
Kung B, et al.
Int J Oncol. 2009 Oct;35(4):845-50. doi: 10.3892/ijo_00000398.
Int J Oncol. 2009.
PMID: 19724921
Free PMC article.
Item in Clipboard
Cite
Cite